Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gilead Sciences (GILD)
NASDAQ:GILD
Gilead Sciences (GILD) Stock Price & Analysis
12,044 Followers
GILD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$72.54 - $86.75
Previous Close$77.65
Volume8.19M
Average Volume (3M)5.74M
Market Cap
$96.76B
Enterprise Value$120.51B
Total Cash (Recent Filing)$1.16B
Total Debt (Recent Filing)$24.98B
Price to Earnings (P/E)16.6
Beta0.54
Next Earnings
Feb 06, 2024EPS Estimate
$1.79Next Dividend Ex-Date
Dec 14, 2023Dividend Yield
3 (3.83%)Share Statistics
EPS (TTM)4.66
Shares Outstanding1,246,041,895
10 Day Avg. Volume5,846,268
30 Day Avg. Volume5,738,289
Standard Deviation0.07
R-Squared0.05
Alpha0.00382
Financial Highlights & Ratios
Price to Book (P/B)-7.36
Price to Sales (P/S)3.55
Price to Cash Flow (P/CF)9.80
P/FCF Ratio9.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.41
Enterprise Value/Gross Profit5.57
Enterprise Value/Ebitda11.27
Forecast
1Y Price Target
$89.71Price Target Upside14.51% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering18
Gilead Sciences News
Ownership Overview
0.67% Insiders
29.80% Mutual Funds
50.59% Other Institutional Investors
18.94% Public Companies and Individual Investors
GILD FAQ
What was Gilead Sciences’s price range in the past 12 months?
Gilead Sciences lowest stock price was $72.54 and its highest was $86.75 in the past 12 months.
What is Gilead Sciences’s market cap?
Currently, no data Available
When is Gilead Sciences’s upcoming earnings report date?
Gilead Sciences’s upcoming earnings report date is Feb 06, 2024 which is in 63 days.
How were Gilead Sciences’s earnings last quarter?
Gilead Sciences released its earnings results on Nov 07, 2023. The company reported $2.29 earnings per share for the quarter, beating the consensus estimate of $1.916 by $0.374.
Is Gilead Sciences overvalued?
According to Wall Street analysts Gilead Sciences’s price is currently Undervalued.
Does Gilead Sciences pay dividends?
Gilead Sciences pays a Quarterly dividend of $0.75 which represents an annual dividend yield of 3.84%. See more information on Gilead Sciences dividends here
What is Gilead Sciences’s EPS estimate?
Gilead Sciences’s EPS estimate is $1.79.
How many shares outstanding does Gilead Sciences have?
Gilead Sciences has 1,246,041,900 shares outstanding.
What happened to Gilead Sciences’s price movement after its last earnings report?
Gilead Sciences reported an EPS of $2.29 in its last earnings report, beating expectations of $1.916. Following the earnings report the stock price went down -3.362%.
Which hedge fund is a major shareholder of Gilead Sciences?
Among the largest hedge funds holding Gilead Sciences’s share is Dodge & Cox. It holds Gilead Sciences’s shares valued at 3B.
---
Gilead Sciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$89.71 (14.51% Upside)
$89.71 (14.51% Upside)
Blogger Sentiment
Bullish
GILD Sentiment 92%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 1.5M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days <0.1%
Last 30 Days ▲ 1.7%
Last 30 Days ▲ 1.7%
News Sentiment
Very Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.32%
12-Months-Change
Fundamentals
Return on Equity
27.08%
Trailing 12-Months
Asset Growth
-0.29%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Gilead Sciences
Founded in 1987, California-based Gilead Sciences, Inc. is a biopharmaceutical company, which focuses on the research, development, and commercialization of antiviral drugs used in the treatment of diseases like human immunodeficiency virus (HIV), hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. It offers its products under brands including Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi.
---
Top 5 ETFs holding GILD
Global X S&P 500 Covered Call ETF
$7.04M
Zacks Earnings Consistent Portfolio ETF
$501.93K
iShares ESG Screened S&P 500 ETF
$485.93K
Global X S&P 500 Covered Call & Growth ETF
$159.17K
Global X S&P 500 ESG Covered Call ETF
$7.35K
Up to five ETFs with an Outperform Smart Score that hold GILD. The ETFs are listed according to market value of GILD within the ETF
---